ES2079366T3 - Inmunoensayo y reactivos para hipertension inducida por embarazo y eclampsia. - Google Patents

Inmunoensayo y reactivos para hipertension inducida por embarazo y eclampsia.

Info

Publication number
ES2079366T3
ES2079366T3 ES89117065T ES89117065T ES2079366T3 ES 2079366 T3 ES2079366 T3 ES 2079366T3 ES 89117065 T ES89117065 T ES 89117065T ES 89117065 T ES89117065 T ES 89117065T ES 2079366 T3 ES2079366 T3 ES 2079366T3
Authority
ES
Spain
Prior art keywords
reagents
pregnancy
eclampsy
induced hypertension
immuno assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89117065T
Other languages
English (en)
Inventor
Andrew E Senyei
Nelson N H Teng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adeza Biomedical Corp
Original Assignee
Adeza Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adeza Biomedical Corp filed Critical Adeza Biomedical Corp
Application granted granted Critical
Publication of ES2079366T3 publication Critical patent/ES2079366T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/321—Arterial hypertension
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA PREECLAMPSIA, HIPERTENSION INDUCIDA POR EMBARAZO (HIP) Y LA ECLAMPSIA SE DETERMINAN IDENTIFICANDO LA PRESENCIA DE UN MARCADOR DE CELULA ENDOTELIAL EN UNA MUESTRA DE SANGRE, PLASMA O SUERO DE UNA MUJER EMBARAZADA UTILIZANDO UN SANDWICH O IMMUNOENSAYO DE COMPETICION. SE DETERMINA EL MARCADOR DE FIBRONECTINA CELULAR EN UNA MUESTRA LIGANDOLO CON UN ANTI(FIBRONECTINA CELULAR) ANTICUERPO. LOS REACTIVOS PARA ESTOS METODOS TAMBIEN CONSTITUYEN UN ASPECTO DE LA PRESENTE INVENCION.
ES89117065T 1988-09-15 1989-09-14 Inmunoensayo y reactivos para hipertension inducida por embarazo y eclampsia. Expired - Lifetime ES2079366T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24497088A 1988-09-15 1988-09-15
US07/302,854 US5079171A (en) 1988-09-15 1989-01-27 Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin

Publications (1)

Publication Number Publication Date
ES2079366T3 true ES2079366T3 (es) 1996-01-16

Family

ID=26936926

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89117065T Expired - Lifetime ES2079366T3 (es) 1988-09-15 1989-09-14 Inmunoensayo y reactivos para hipertension inducida por embarazo y eclampsia.

Country Status (10)

Country Link
US (1) US5079171A (es)
EP (1) EP0359274B1 (es)
JP (1) JP2597013B2 (es)
AT (1) ATE130437T1 (es)
AU (1) AU623678B2 (es)
CA (1) CA1338899C (es)
DE (1) DE68924818T2 (es)
ES (1) ES2079366T3 (es)
GR (1) GR3018101T3 (es)
IL (1) IL91639A0 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI892197A7 (fi) * 1989-05-08 1990-11-09 Locus Oy Foerfarande foer detektering av tumoerer.
WO1991016633A1 (en) * 1990-04-12 1991-10-31 Adeza Biomedical Corporation Pregnancy induced hypertension and eclampsia immunoassay and reagents
WO1992017604A1 (fr) * 1991-03-26 1992-10-15 Otsuka Pharmaceutical Factory, Inc. Anticorps monoclonal anti-eda
EP0584343B1 (en) * 1992-03-10 1999-01-20 La Jolla Cancer Research Foundation Recombinant calf intestinal alkaline phosphatase
US5543138A (en) * 1994-03-10 1996-08-06 Genetics Institute, Inc. Methods of diagnosing and treating preeclampsia
US6143510A (en) * 1994-07-29 2000-11-07 Iatron Laboratories Inc. Measuring method using whole blood sample
US5849474A (en) * 1995-12-06 1998-12-15 Olson; Camilla M. Diagnosis of preeclampsia in mammals
GB9614615D0 (en) * 1996-07-11 1996-09-04 Isis Innovation Diagnosis of pre-eclampsia
US6620590B2 (en) 1996-07-11 2003-09-16 Isis Innovation Limited Diagnosis of pre-eclampsia
DE19631192C2 (de) * 1996-08-03 1998-09-10 Hellmut Dr Augustin Verfahren zur Früherkennung gestosegefährdeter schwangerer Frauen
US6267722B1 (en) 1998-02-03 2001-07-31 Adeza Biomedical Corporation Point of care diagnostic systems
US6394952B1 (en) * 1998-02-03 2002-05-28 Adeza Biomedical Corporation Point of care diagnostic systems
US6284194B1 (en) 1998-03-11 2001-09-04 Albert E. Chu Analytical assay device and methods using surfactant treated membranes to increase assay sensitivity
USD434153S (en) * 1998-04-20 2000-11-21 Adeza Biomedical Corporation Point of care analyte detector system
USD432244S (en) * 1998-04-20 2000-10-17 Adeza Biomedical Corporation Device for encasing an assay test strip
GB9927125D0 (en) * 1999-11-16 2000-01-12 Univ Reading The Placental human neurokinin B precursor
US6642055B1 (en) 2000-03-31 2003-11-04 Arbogast Pharmaceuticals, Inc. Method for the prediction of preeclampsia and other diseases
BRPI0407213A (pt) * 2003-02-04 2006-02-07 Univ Tulane Método de emprego da elevação de marinobufagenina na determinação da presença de pré-eclampsia e aparelhos relacionados
US20040266025A1 (en) 2003-02-06 2004-12-30 Durlin Hickok Screening and treatment methods for prevention of preterm delivery
US7634360B2 (en) * 2003-09-23 2009-12-15 Prediction Sciences, LL Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
US20080010024A1 (en) * 2003-09-23 2008-01-10 Prediction Sciences Llp Cellular fibronectin as a diagnostic marker in cardiovascular disease and methods of use thereof
US7392140B2 (en) * 2003-09-23 2008-06-24 Prediction Sciences, Llc Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
JP2008514900A (ja) * 2004-07-30 2008-05-08 アデザ・バイオメデイカル・コーポレイシヨン 疾病および他の状態のマーカーとしての癌胎児性フィブロネクチンならびに癌胎児性フィブロネクチンの検出のための方法
DE602005023216D1 (de) * 2004-12-15 2010-10-07 Beth Israel Hospital Nukleinsäuren und polypeptide zur diagnose und behandlung von schwangerschaftskomplikationen
CN101616927A (zh) * 2005-09-15 2009-12-30 迪爱麦有限公司 诊断先兆子痫的方法
EA022609B1 (ru) 2007-02-12 2016-02-29 А1М Фарма Аб Применение свободного фетального гемоглобина в качестве маркера преэклампсии
WO2009097584A1 (en) * 2008-01-30 2009-08-06 Proteogenix, Inc. Maternal serum biomarkers for detection of pre-eclampsia
HRP20150802T1 (xx) 2010-03-24 2015-11-06 Preelumina Diagnostics Ab Hbf i a1m kao markeri za rano otkrivanje preeklampsije
BR112013007311A2 (pt) 2010-10-01 2016-07-05 Hologic Inc tira de teste de imunoensaio para uso em um sistema de diagnóstico
EP2726631A1 (en) 2011-06-28 2014-05-07 Vitateq Biotechnology GmbH Method for diagnosing preeclampsia
EP2836843B1 (en) * 2012-04-13 2020-07-08 Prediction Biosciences S.A.S. Rapid test for cellular fibronectin
RU2740852C1 (ru) * 2020-07-27 2021-01-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Ростовский государственный университет" Министерства здравоохранения Российской Федерации Способ прогнозирования преэклампсии у беременных с гестационным сахарным диабетом

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0616048B2 (ja) * 1983-10-26 1994-03-02 帝国臓器製薬株式会社 フィブロネクチンの免疫学的測定
US4980279A (en) * 1986-04-15 1990-12-25 Scripps Clinic And Research Foundation Cellular fibronectin: polypeptides, anti-polypeptide antibodies and assay methods

Also Published As

Publication number Publication date
ATE130437T1 (de) 1995-12-15
AU623678B2 (en) 1992-05-21
DE68924818D1 (de) 1995-12-21
AU4131689A (en) 1990-03-22
CA1338899C (en) 1997-02-11
GR3018101T3 (en) 1996-02-29
DE68924818T2 (de) 1996-05-02
IL91639A0 (en) 1990-04-29
JP2597013B2 (ja) 1997-04-02
US5079171A (en) 1992-01-07
EP0359274A2 (en) 1990-03-21
EP0359274A3 (en) 1990-11-28
JPH02115767A (ja) 1990-04-27
EP0359274B1 (en) 1995-11-15

Similar Documents

Publication Publication Date Title
ES2079366T3 (es) Inmunoensayo y reactivos para hipertension inducida por embarazo y eclampsia.
ATE228247T1 (de) Testreagentien und testvorrichtungen
ES556865A0 (es) Un metodo de inmunoensayo.
ES2001811A6 (es) Un nuevo material y un nuevo dispositivo utiles en ensayos de fijacionen fase solida para determinar la presencia o la cantidad de un analito en una muestra de ensayo
GB8915512D0 (en) Silver enhanced gold-labelled immuno assay method
ATE430939T1 (de) Schwangerschaftsnachweisverfahren
DE3878820D1 (de) Vorrichtung fuer bindungstest.
EP0387027A3 (en) Endometriosis diagnosis methods and reagents
ES2054686T3 (es) Equipo de inmunoensayo.
ES2131279T3 (es) Inmunoensayo de tipo sandwich para n-peptido.
DE69431621D1 (de) Methode zur detektion von rissen in amniomembranen bei schwangeren säugetieren
NO884131D0 (no) Agglutineringsreagens og dets anvendelse for detektering av antigene antistoffer eller andre analyter.
EP0324969A3 (en) Method of measuring transferrin
DE3568639D1 (en) Method for the determination of a substance capable of immunological binding
EP0321249A3 (en) Agent for and method of diagnosis of varicella zoster virus infection
ES2029890T3 (es) Inmunoensayo.
NO903830D0 (no) Fremgangsmaate for aa bestemme antistoff og assayreagens for dette.
RU96112671A (ru) Способ и набор для обнаружения антител к вирусу лихорадки долины рифт в сыворотках животных
SE9900875D0 (sv) Antinuclear antibody assay utilizing stress-treated cells or cell extracts
KR890702040A (ko) 요중의 염기성 태아단백의 측정방법 및 그것에 사용되는 측정키트

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 359274

Country of ref document: ES